Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Correction to: Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022

Correction to: Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of... Open Forum Infectious Diseases CORRECTION Correction to: Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022 In the original publication of this article, [Lewis NM, Murray Open Forum Infectious Diseases, Volume 10, Issue 1, N, Adams K et al. Correction to: Absolute and Relative January 2023, ofac698, https://doi.org/10.1093/ofid/ofac698 ], Vaccine Effectiveness of Primary and Booster Series of there was a duplicate sentence in the introductory paragraph COVID-19 Vaccines (mRNA and Adenovirus Vector) on page 2 which has been removed, and Figure 1 has been re- Against COVID-19 Hospitalizations in the United States, placed with an updated version due to an error with the plot December 2021–April 2022, Open Forum Infectious Diseases, lines that does not affect overall interpretation of the data. Open Forum Infectious Diseases © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons. org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Open Forum Infectious Diseases Oxford University Press

Correction to: Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022

Open Forum Infectious Diseases , Volume 10 (5): 1 – May 10, 2023
Download PDF
1 page

Loading next page...
 
/lp/oxford-university-press/correction-to-absolute-and-relative-vaccine-effectiveness-of-primary-FQmUBmeGtP

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Oxford University Press
Copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
eISSN
2328-8957
DOI
10.1093/ofid/ofad252
Publisher site
See Article on Publisher Site

Abstract

Open Forum Infectious Diseases CORRECTION Correction to: Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022 In the original publication of this article, [Lewis NM, Murray Open Forum Infectious Diseases, Volume 10, Issue 1, N, Adams K et al. Correction to: Absolute and Relative January 2023, ofac698, https://doi.org/10.1093/ofid/ofac698 ], Vaccine Effectiveness of Primary and Booster Series of there was a duplicate sentence in the introductory paragraph COVID-19 Vaccines (mRNA and Adenovirus Vector) on page 2 which has been removed, and Figure 1 has been re- Against COVID-19 Hospitalizations in the United States, placed with an updated version due to an error with the plot December 2021–April 2022, Open Forum Infectious Diseases, lines that does not affect overall interpretation of the data. Open Forum Infectious Diseases © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons. org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed

Journal

Open Forum Infectious Diseases – Oxford University Press

Published: May 10, 2023

There are no references for this article.